Your search for "Press release" return 97 results.
Ceva posts strong double-digit growth again in H1 2015 >
Libourne 22 nd July 2015 - Consolidated sales of the Ceva Group reached €424m at the end of June 2015, representing growth of 16% and +12% at constant perimeter and exchange rates. Sales grew in all...
Ceva’s new generation Vectormune® AI vaccine proves to be a useful tool to control HPAI >
A paper* recently published in the peer-reviewed journal Vaccine** reports that Ceva’s new generation vaccine, Vectormune® AI, offers significant advantages over previously available vaccines against...
Troublesome cats get first online resource >
A new online resource to help veterinary students, practitioners and pet owners better understand the undesirable behaviour of cats
Ceva posts strong double-digit growth again in 2014 >
Consolidated sales of the Ceva Group reached €766m at the end of 2014, representing growth of 23% and +14.1% at a constant perimeter and exchange rates.
Ceva “State of the Art” Summit at VIV Asia 2015 >
Ceva’s poultry, swine, services & equipment teams will focus on what is “State of the Art” in animal production during the VIV Asia international trade show to be held in Bangkok from March 11th - 13t...
Ceva US Joins Fear Free™ Initiative As Inaugural Industry Sponsor >
Ceva today announced its commitment to Fear Free,™ an innovative initiative developed by “America’s Veterinarian” Dr. Marty Becker to in his words, “take the pet out of petrified and get pets back int...
Egypt study confirms that a single rHVT-H5 hatchery vaccination could be an effective tool to address A/H5N1 prevention >
Research confirms that in endemic countries the classical inactivated vaccines are less effective and hard to administer, while application of a rHVT vector hatchery vaccine is labour saving, cost eff...
Mérieux Développement becomes a shareholder of Ceva Santé Animale >
Ceva Santé Animale announces the arrival of a new shareholder, Mérieux Développement, the investment company of Institut Mérieux.
Ceva Santé Animale reinforces its pharmaceutical production capacity, opening a new plant at its headquarters in Libourne France >
Libourne, 3 October 2014 – Ceva Santé Animale, the global veterinary health group, has invested €18 million in renovating and extending its sterile products plant in Libourne. The new industrial facil...
Ceva merges all R&D activity and nominates Dr. Steve Chu as member of the Executive Committee >
Libourne 4th September 2014 - Ceva Santé Animale announced the appointment of Dr.Chu to its executive committee with responsibility for all R&D activities. The move recognises the growing importan...